| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 247.548.004 $ | 100,07 | 6.040.675 | |||||||
| United Therapeutics Corp. | United Therapeutics Corp. | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 15.547.576 $ | 6,28 | 27.212 | |
| Illumina, Inc. | Illumina, Inc. | EC | 452327109 | Long | Börsenkurs (Stufe 1) | 13.286.408 $ | 5,37 | 104.832 | |
| Biogen Inc. | Biogen Inc. | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 12.497.212 $ | 5,05 | 66.025 | |
| Incyte Corp. | Incyte Corp. | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 12.146.830 $ | 4,91 | 127.499 | |
| Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals, Inc. | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 11.979.120 $ | 4,84 | 38.706 | |
| Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 11.796.589 $ | 4,77 | 16.684 | |
| Amgen Inc. | Amgen Inc. | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 11.651.659 $ | 4,71 | 33.651 | |
| Gilead Sciences, Inc. | Gilead Sciences, Inc. | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 11.417.622 $ | 4,62 | 87.264 | |
| BioCryst Pharmaceuticals, Inc. | BioCryst Pharmaceuticals, Inc. | EC | 09058V103 | Long | Börsenkurs (Stufe 1) | 8.458.875 $ | 3,42 | 923.458 | |
| Catalyst Pharmaceuticals, Inc. | Catalyst Pharmaceuticals, Inc. | EC | 14888U101 | Long | Börsenkurs (Stufe 1) | 8.172.131 $ | 3,30 | 290.513 | |
| Arrowhead Pharmaceuticals, Inc. | Arrowhead Pharmaceuticals, Inc. | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 8.110.282 $ | 3,28 | 110.374 | |
| Protagonist Therapeutics, Inc. | Protagonist Therapeutics, Inc. | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 7.958.673 $ | 3,22 | 80.415 | |
| TG Therapeutics, Inc. | TG Therapeutics, Inc. | EC | 88322Q108 | Long | Börsenkurs (Stufe 1) | 7.780.716 $ | 3,15 | 230.335 | |
| Royalty Pharma PLC | Royalty Pharma PLC, Class A | EC | G7709Q104 | Long | Börsenkurs (Stufe 1) | 7.753.481 $ | 3,13 | 154.791 | |
| CareDx, Inc. | CareDx, Inc. | EC | 14167L103 | Long | Börsenkurs (Stufe 1) | 7.597.003 $ | 3,07 | 365.065 | |
| Neurocrine Biosciences, Inc. | Neurocrine Biosciences, Inc. | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 7.065.412 $ | 2,86 | 53.660 | |
| Exelixis, Inc. | Exelixis, Inc. | EC | 30161Q104 | Long | Börsenkurs (Stufe 1) | 6.921.622 $ | 2,80 | 155.682 | |
| Bio-Techne Corp. | Bio-Techne Corp. | EC | 09073M104 | Long | Börsenkurs (Stufe 1) | 6.749.261 $ | 2,73 | 122.004 | |
| PTC Therapeutics, Inc. | PTC Therapeutics, Inc. | EC | 69366J200 | Long | Börsenkurs (Stufe 1) | 6.628.118 $ | 2,68 | 101.877 | |
| Veracyte, Inc. | Veracyte, Inc. | EC | 92337F107 | Long | Börsenkurs (Stufe 1) | 6.482.047 $ | 2,62 | 196.903 | |
| Acadia Pharmaceuticals Inc. | Acadia Pharmaceuticals Inc. | EC | 004225108 | Long | Börsenkurs (Stufe 1) | 6.415.918 $ | 2,59 | 285.787 | |
| Vericel Corp. | Vericel Corp. | EC | 92346J108 | Long | Börsenkurs (Stufe 1) | 6.380.804 $ | 2,58 | 183.726 | |
| Halozyme Therapeutics, Inc. | Halozyme Therapeutics, Inc. | EC | 40637H109 | Long | Börsenkurs (Stufe 1) | 6.358.361 $ | 2,57 | 99.880 | |
| Repligen Corp. | Repligen Corp. | EC | 759916109 | Long | Börsenkurs (Stufe 1) | 6.173.771 $ | 2,50 | 52.183 | |
| Theravance Biopharma Inc. | Theravance Biopharma Inc. | EC | G8807B106 | Long | Börsenkurs (Stufe 1) | 6.172.105 $ | 2,49 | 368.704 | |
| Ionis Pharmaceuticals, Inc. | Ionis Pharmaceuticals, Inc. | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 6.148.262 $ | 2,49 | 82.240 | |
| BioMarin Pharmaceutical Inc. | BioMarin Pharmaceutical Inc. | EC | 09061G101 | Long | Börsenkurs (Stufe 1) | 6.050.050 $ | 2,45 | 112.225 | |
| Collegium Pharmaceutical, Inc. | Collegium Pharmaceutical, Inc. | EC | 19459J104 | Long | Börsenkurs (Stufe 1) | 5.247.646 $ | 2,12 | 155.578 | |
| Qiagen N.V. | Qiagen N.V. | EC | N72482156 | Long | Börsenkurs (Stufe 1) | 5.010.586 $ | 2,03 | 144.898 | |
| MannKind Corp. | MannKind Corp. | EC | 56400P706 | Long | Börsenkurs (Stufe 1) | 3.589.866 $ | 1,45 | 1.268.504 | |
| 247.548.004 $ | 100,07 | 6.040.675 |